Leonieke J J van Mens (Leonieke van Mens, Leonieke Jj van Mens)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 11

Top Topics

Prostate Cancer

Juvenile Idiopathic Arthritis

Top Venues

The Journal of rheumatology

The Journal of rheumatology. Supplement

Annals of the rheumatic diseases

This page only lists publications with an associated author ORCID identifier.

Publications

Hanna J Johnsson, Gizem Ayan, Roxana Coras, Rachel Grynszpan, Sebastián Herrera, Hannah Jethwa, Dimitri Luz Felipe da Silva, Michelle L M Mulder, David Simon, Arani Vivekanantham, Leonieke J J van Mens, Fabian Proft
Young-GRAPPA 2023: The Future Is Bright. The Journal of rheumatology (2024)
Gizem Ayan, Roxana Coras, Rachel Grynszpan, Sebastián Herrera, Hannah Jethwa, Hanna J Johnsson, Leonieke J J van Mens, Michelle L M Mulder, David Simon, Arani Vivekanantham, Fabian Proft
Young-GRAPPA (Y-GRAPPA) at the GRAPPA 2022 Annual Meeting: One Year in Y-GRAPPA. Where Do We Stand, Where Do We Go? The Journal of rheumatology (2023)
Neelam Hassan, Leonieke J J van Mens, Uta Kiltz, Laura Andreoli, Concha Delgado-Beltran, Pavel V Ovseiko, Laure Gossec, Laura C Coates
Gender equity in academic rheumatology: is there a gender gap at European rheumatology conferences? RMD open 8 (1) (2022)
Carmel Stober, Iain B McInnes, Soumya Raychaudhuri, Phillip J Mease, Stephen R Pennington, Jose U Scher, Vinod Chandran, April W Armstrong, Maarten P T de Wit, Alberto Cauli, Deepak R Jadon, Thorvardur Jon Love, Philip S Helliwell, Denis O'Sullivan, Leonieke J J van Mens, Christopher T Ritchlin, Oliver M FitzGerald
Proceedings of the 2021 GRAPPA-Collaborative Research Network (CRN) Meeting. The Journal of rheumatology 49 (6 Suppl 1) (2022)
Leonieke J J van Mens, Gizem Ayan, Laura C Coates, Roxana Coras, Dimitri Luz Felipe da Silva, Sebastián Herrera, Alla Ishchenko, Hannah Jethwa, Hanna J Johnsson, David Simon, Arani Vivekanantham, Fabian Proft
Young-GRAPPA at the Annual GRAPPA Meeting: Presentation of a New Group Within GRAPPA and Its Vision. The Journal of rheumatology 49 (6 Suppl 1) (2022)
Catherine D Hughes, Leonieke J J van Mens, Wolf-Henning Boehncke, Christopher T Ritchlin
GRAPPA Trainees Symposium 2019: A Report from the GRAPPA 2019 Annual Meeting. The Journal of rheumatology. Supplement 96 (2021)
Robin Waxman, Carmel Stober, Deepak R Jadon, Ana Maria Orbai, Vinod Chandran, Philip S Helliwell, Stephen R Pennington, Maarten de Wit, Denis O'Sullivan, Phillip J Mease, April W Armstrong, Kristina Callis Duffin, Philip S Helliwell, Leonieke J J van Mens, Christopher T Ritchlin, Oliver M FitzGerald
Proceedings of the 2019 GRAPPA Collaborative Research Network Meeting. The Journal of rheumatology. Supplement 96 (2021)
Carmel Stober, Deepak R Jadon, April W Armstrong, Vinod Chandran, Maarten de Wit, Philip S Helliwell, Phillip J Mease, Philip S Helliwell, Denis O'Sullivan, Stephen R Pennington, Thorvardur Jon Love, Alberto Cauli, Leonieke J J van Mens, Robin Waxman, Jose U Scher, Richard B Warren, Christopher T Ritchlin, Oliver M FitzGerald
Proceedings of the 2020 GRAPPA Collaborative Research Network (CRN) Meeting. The Journal of rheumatology (2021)
Carmel Stober, Deepak R Jadon, April W Armstrong, Vinod Chandran, Maarten de Wit, Philip S Helliwell, Phillip J Mease, Philip S Helliwell, Denis O'Sullivan, Stephen R Pennington, Thorvardur Jon Love, Alberto Cauli, Leonieke J J van Mens, Robin Waxman, Jose U Scher, Richard B Warren, Christopher T Ritchlin, Oliver M FitzGerald
Proceedings of the 2020 GRAPPA Collaborative Research Network (CRN) Meeting. The Journal of rheumatology. Supplement 97 (2021)
Leonieke J J van Mens, Marleen G H van de Sande, Arno W R van Kuijk, Dominique Baeten, Laura C Coates
Treat to target in PsA should focus on clinical measures. Response to: 'DAPSA versus cDAPSA: do we need to use CRP?' by Gonçalves et al. Annals of the rheumatic diseases 79 (11) (2019)
Leonieke J J van Mens, Henriëtte M de Jong, Inka Fluri, Michael T Nurmohamed, Marleen G H van de Sande, Marc Kok, Arno W R van Kuijk, Dominique Baeten
Achieving remission in psoriatic arthritis by early initiation of TNF inhibition: a double-blind, randomised, placebo-controlled trial of golimumab plus methotrexate versus placebo plus methotrexate. Annals of the rheumatic diseases 78 (5) (2019)